Manulife (Manufacturers Life Insurance)’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,998
| Closed | -$21K | – | 2993 |
|
|
2025
Q1 | $21K | Sell |
13,998
-944
| -6% | -$2.38K | ﹤0.01% | 2885 |
|
|
2024
Q4 | $35.3K | Sell |
14,942
-300
| -2% | -$5.27K | ﹤0.01% | 2951 |
|
|
2024
Q3 | $449K | Sell |
15,242
-7,458
| -33% | -$172K | ﹤0.01% | 2329 |
|
|
2024
Q2 | $280K | Buy |
22,700
+2,377
| +12% | +$50.1K | ﹤0.01% | 2450 |
|
|
2024
Q1 | $412K | Buy |
20,323
+5,087
| +33% | +$117K | ﹤0.01% | 2275 |
|
|
2023
Q4 | $343K | Sell |
15,236
-356
| -2% | -$7.52K | ﹤0.01% | 2346 |
|
|
2023
Q3 | $259K | Sell |
15,592
-611
| -4% | -$12.1K | ﹤0.01% | 2447 |
|
|
2023
Q2 | $397K | Buy |
16,203
+774
| +5% | +$18.6K | ﹤0.01% | 2187 |
|
|
2023
Q1 | $372K | Buy |
15,429
+655
| +4% | +$18.1K | ﹤0.01% | 2190 |
|
|
2022
Q4 | $436K | Sell |
14,774
-170
| -1% | -$6.11K | ﹤0.01% | 2079 |
|
|
2022
Q3 | $625K | Sell |
14,944
-637
| -4% | -$17.2K | ﹤0.01% | 1839 |
|
|
2022
Q2 | $438K | Sell |
15,581
-119
| -0.8% | -$3K | ﹤0.01% | 2139 |
|
|
2022
Q1 | $583K | Sell |
15,700
-3,657
| -19% | -$155K | ﹤0.01% | 2106 |
|
|
2021
Q4 | $846 | Sell |
19,357
-352
| -2% | -$18.5K | ﹤0.01% | 1945 |
|
|
2021
Q3 | $1.22M | Sell |
19,709
-1,627
| -8% | -$136K | ﹤0.01% | 1713 |
|
|
2021
Q2 | $1.82M | Buy |
21,336
+3,664
| +21% | +$196K | ﹤0.01% | 1648 |
|
|
2021
Q1 | $794K | Sell |
17,672
-2,697
| -13% | -$106K | ﹤0.01% | 2017 |
|
|
2020
Q4 | $139K | Buy |
20,369
+7,107
| +54% | +$63.5K | ﹤0.01% | 2890 |
|
|
2020
Q3 | $153K | Buy |
+13,262
| New | +$59.8K | ﹤0.01% | 2669 |
|
|
2017
Q2 | – | Sell |
-69
| Closed | – | – | 4435 |
|
|
2017
Q1 | $0 | Hold |
69
| – | – | ﹤0.01% | 4353 |
|
|
2016
Q4 | $0 | Hold |
69
| – | – | ﹤0.01% | 4439 |
|
|
2016
Q3 | $0 | Hold |
69
| – | – | ﹤0.01% | 4344 |
|
|
2016
Q2 | $1K | Buy |
+69
| New | +$1.09K | ﹤0.01% | 4135 |
|
|
2014
Q4 | – | Sell |
-3,856
| Closed | -$106 | – | 4021 |
|
|
2014
Q3 | $106 | Buy |
3,856
+2
| +0.1% | +$61 | ﹤0.01% | 3076 |
|
|
2014
Q2 | $155K | Buy |
3,854
+3,592
| +1,371% | +$133K | ﹤0.01% | 2915 |
|
|
2014
Q1 | $10 | Hold |
262
| – | – | ﹤0.01% | 3367 |
|
|
2013
Q4 | $9 | Buy |
262
+61
| +30% | +$1.62K | ﹤0.01% | 3383 |
|
|
2013
Q3 | $4 | Sell |
201
-72
| -26% | -$1.26K | ﹤0.01% | 3414 |
|
|
2013
Q2 | $4K | Buy |
+273
| New | +$5.77K | ﹤0.01% | 3314 |
|
Other funds holding FLNA
GC
Manulife (Manufacturers Life Insurance)'s FLNA Position: Q2 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 13,998 shares — an estimated $21K sold.
Manulife (Manufacturers Life Insurance) first reported a position in FLNA in Q2 2013 and held it in 29 quarters. The position peaked at $1.82M in Q2 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 13,998 Filana Therapeutics shares in Q2 2025, an estimated $21K.
- Manulife (Manufacturers Life Insurance) first reported a position in Filana Therapeutics in Q2 2013 and held it in 29 quarters.
- Manulife (Manufacturers Life Insurance)'s Filana Therapeutics position peaked at $1.82M in Q2 2021.
- 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.